Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism
OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increas...
Gespeichert in:
Veröffentlicht in: | Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2008-07, Vol.28 (7), p.1361-1367 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1367 |
---|---|
container_issue | 7 |
container_start_page | 1361 |
container_title | Arteriosclerosis, thrombosis, and vascular biology |
container_volume | 28 |
creator | Fuhrman, Bianca Khateeb, Jasmin Shiner, Maayan Nitzan, Orna Karry, Rachel Volkova, Nina Aviram, Michael |
description | OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress.
METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress.
CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis. |
doi_str_mv | 10.1161/ATVBAHA.108.166041 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69235184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69235184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</originalsourceid><addsrcrecordid>eNpFkU9v0zAYhy0EYqPwBTggX-CW8vpv0mPYBkXaWA_rrpGXvGnNEruzE9ZJ-_C4awQHy37l5_eT_JiQjwzmjGn2tby5_VYuyzmDYs60BslekVOmuMykFvp1OkO-yJSW_IS8i_E3AEjO4S05YYUUugB5Sp7Xwd9bZyLSVWdib53foKNlPdg_ZvCBrncBN2NnBox0ZYLxe_9Cc3qxT1cxWu-odfTK1MHvtmaTuFtrqHH0V3m-WtLrvW1SIDvHHboG3UCvsN4aZ2P_nrxpTRfxw7TPyPr7xc3ZMru8_vHzrLzMaqlkkUl-ByBQCaFapkXTcqbaPK9VzlWhmWj5AgEaBG0apXgjJBQihwTDAvLaiBn5cuzdBf8wYhyq3sYau8449GOs9IILdXAyI_wIprfEGLCtdsH2JjxVDKqD82pynuaiOjpPoU9T-3jXY_M_MklOwOcJMLE2XRuMq238x3GQKi9eiuSRe_TdgCHed-MjhmqLphu21eH3hAaVcYAC8jRmafFC_AX5X5kp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69235184</pqid></control><display><type>article</type><title>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Fuhrman, Bianca ; Khateeb, Jasmin ; Shiner, Maayan ; Nitzan, Orna ; Karry, Rachel ; Volkova, Nina ; Aviram, Michael</creator><creatorcontrib>Fuhrman, Bianca ; Khateeb, Jasmin ; Shiner, Maayan ; Nitzan, Orna ; Karry, Rachel ; Volkova, Nina ; Aviram, Michael</creatorcontrib><description>OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress.
METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress.
CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.108.166041</identifier><identifier>PMID: 18436804</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Acetophenones - pharmacology ; Animals ; Antioxidants - pharmacology ; Aryldialkylphosphatase - biosynthesis ; Aryldialkylphosphatase - genetics ; Aryldialkylphosphatase - metabolism ; Atherosclerosis (general aspects, experimental research) ; Atherosclerosis - enzymology ; Atherosclerosis - metabolism ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular system ; Cell Line, Tumor ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Enzyme Activation ; Enzyme Induction ; Humans ; Lipid Peroxidation ; Lipoproteins, LDL - metabolism ; Macrophages - drug effects ; Macrophages - enzymology ; Macrophages - metabolism ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; Miscellaneous ; NADPH Oxidases - deficiency ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Oxidative Stress - drug effects ; Pharmacology. Drug treatments ; Plant Extracts - pharmacology ; Punicaceae ; Reactive Oxygen Species - metabolism ; Receptors, Cell Surface - deficiency ; Receptors, Cell Surface - genetics ; Receptors, Cell Surface - metabolism ; Receptors, Urokinase Plasminogen Activator ; RNA, Messenger - metabolism ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2008-07, Vol.28 (7), p.1361-1367</ispartof><rights>2008 American Heart Association, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</citedby><cites>FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20457841$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18436804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fuhrman, Bianca</creatorcontrib><creatorcontrib>Khateeb, Jasmin</creatorcontrib><creatorcontrib>Shiner, Maayan</creatorcontrib><creatorcontrib>Nitzan, Orna</creatorcontrib><creatorcontrib>Karry, Rachel</creatorcontrib><creatorcontrib>Volkova, Nina</creatorcontrib><creatorcontrib>Aviram, Michael</creatorcontrib><title>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress.
METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress.
CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.</description><subject>Acetophenones - pharmacology</subject><subject>Animals</subject><subject>Antioxidants - pharmacology</subject><subject>Aryldialkylphosphatase - biosynthesis</subject><subject>Aryldialkylphosphatase - genetics</subject><subject>Aryldialkylphosphatase - metabolism</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Atherosclerosis - enzymology</subject><subject>Atherosclerosis - metabolism</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Cell Line, Tumor</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Enzyme Activation</subject><subject>Enzyme Induction</subject><subject>Humans</subject><subject>Lipid Peroxidation</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - enzymology</subject><subject>Macrophages - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Miscellaneous</subject><subject>NADPH Oxidases - deficiency</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Oxidative Stress - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - pharmacology</subject><subject>Punicaceae</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Receptors, Cell Surface - deficiency</subject><subject>Receptors, Cell Surface - genetics</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>Receptors, Urokinase Plasminogen Activator</subject><subject>RNA, Messenger - metabolism</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU9v0zAYhy0EYqPwBTggX-CW8vpv0mPYBkXaWA_rrpGXvGnNEruzE9ZJ-_C4awQHy37l5_eT_JiQjwzmjGn2tby5_VYuyzmDYs60BslekVOmuMykFvp1OkO-yJSW_IS8i_E3AEjO4S05YYUUugB5Sp7Xwd9bZyLSVWdib53foKNlPdg_ZvCBrncBN2NnBox0ZYLxe_9Cc3qxT1cxWu-odfTK1MHvtmaTuFtrqHH0V3m-WtLrvW1SIDvHHboG3UCvsN4aZ2P_nrxpTRfxw7TPyPr7xc3ZMru8_vHzrLzMaqlkkUl-ByBQCaFapkXTcqbaPK9VzlWhmWj5AgEaBG0apXgjJBQihwTDAvLaiBn5cuzdBf8wYhyq3sYau8449GOs9IILdXAyI_wIprfEGLCtdsH2JjxVDKqD82pynuaiOjpPoU9T-3jXY_M_MklOwOcJMLE2XRuMq238x3GQKi9eiuSRe_TdgCHed-MjhmqLphu21eH3hAaVcYAC8jRmafFC_AX5X5kp</recordid><startdate>200807</startdate><enddate>200807</enddate><creator>Fuhrman, Bianca</creator><creator>Khateeb, Jasmin</creator><creator>Shiner, Maayan</creator><creator>Nitzan, Orna</creator><creator>Karry, Rachel</creator><creator>Volkova, Nina</creator><creator>Aviram, Michael</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200807</creationdate><title>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</title><author>Fuhrman, Bianca ; Khateeb, Jasmin ; Shiner, Maayan ; Nitzan, Orna ; Karry, Rachel ; Volkova, Nina ; Aviram, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acetophenones - pharmacology</topic><topic>Animals</topic><topic>Antioxidants - pharmacology</topic><topic>Aryldialkylphosphatase - biosynthesis</topic><topic>Aryldialkylphosphatase - genetics</topic><topic>Aryldialkylphosphatase - metabolism</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Atherosclerosis - enzymology</topic><topic>Atherosclerosis - metabolism</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Cell Line, Tumor</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Enzyme Activation</topic><topic>Enzyme Induction</topic><topic>Humans</topic><topic>Lipid Peroxidation</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - enzymology</topic><topic>Macrophages - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Miscellaneous</topic><topic>NADPH Oxidases - deficiency</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Oxidative Stress - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - pharmacology</topic><topic>Punicaceae</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Receptors, Cell Surface - deficiency</topic><topic>Receptors, Cell Surface - genetics</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>Receptors, Urokinase Plasminogen Activator</topic><topic>RNA, Messenger - metabolism</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fuhrman, Bianca</creatorcontrib><creatorcontrib>Khateeb, Jasmin</creatorcontrib><creatorcontrib>Shiner, Maayan</creatorcontrib><creatorcontrib>Nitzan, Orna</creatorcontrib><creatorcontrib>Karry, Rachel</creatorcontrib><creatorcontrib>Volkova, Nina</creatorcontrib><creatorcontrib>Aviram, Michael</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fuhrman, Bianca</au><au>Khateeb, Jasmin</au><au>Shiner, Maayan</au><au>Nitzan, Orna</au><au>Karry, Rachel</au><au>Volkova, Nina</au><au>Aviram, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2008-07</date><risdate>2008</risdate><volume>28</volume><issue>7</issue><spage>1361</spage><epage>1367</epage><pages>1361-1367</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress.
METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress.
CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>18436804</pmid><doi>10.1161/ATVBAHA.108.166041</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1079-5642 |
ispartof | Arteriosclerosis, thrombosis, and vascular biology, 2008-07, Vol.28 (7), p.1361-1367 |
issn | 1079-5642 1524-4636 |
language | eng |
recordid | cdi_proquest_miscellaneous_69235184 |
source | MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection |
subjects | Acetophenones - pharmacology Animals Antioxidants - pharmacology Aryldialkylphosphatase - biosynthesis Aryldialkylphosphatase - genetics Aryldialkylphosphatase - metabolism Atherosclerosis (general aspects, experimental research) Atherosclerosis - enzymology Atherosclerosis - metabolism Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular system Cell Line, Tumor Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Enzyme Activation Enzyme Induction Humans Lipid Peroxidation Lipoproteins, LDL - metabolism Macrophages - drug effects Macrophages - enzymology Macrophages - metabolism Medical sciences Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Miscellaneous NADPH Oxidases - deficiency NADPH Oxidases - genetics NADPH Oxidases - metabolism Oxidative Stress - drug effects Pharmacology. Drug treatments Plant Extracts - pharmacology Punicaceae Reactive Oxygen Species - metabolism Receptors, Cell Surface - deficiency Receptors, Cell Surface - genetics Receptors, Cell Surface - metabolism Receptors, Urokinase Plasminogen Activator RNA, Messenger - metabolism Urokinase-Type Plasminogen Activator - metabolism |
title | Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A25%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urokinase%20Plasminogen%20Activator%20Upregulates%20Paraoxonase%202%20Expression%20in%20Macrophages%20Via%20an%20NADPH%20Oxidase-Dependent%20Mechanism&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Fuhrman,%20Bianca&rft.date=2008-07&rft.volume=28&rft.issue=7&rft.spage=1361&rft.epage=1367&rft.pages=1361-1367&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/ATVBAHA.108.166041&rft_dat=%3Cproquest_cross%3E69235184%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69235184&rft_id=info:pmid/18436804&rfr_iscdi=true |